Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SB-269970 hydrochloride (SB-269970A) 是 SB-269970 的盐酸盐形式,是一种 5-HT7 受体拮抗剂,pKi 值为 8.3,对其选择性比其他 5-HT 受体大于50倍多。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 323 | 现货 | ||
5 mg | ¥ 696 | 现货 | ||
10 mg | ¥ 1,134 | 现货 | ||
25 mg | ¥ 2,132 | 现货 | ||
50 mg | ¥ 3,767 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,248 | 现货 |
产品描述 | SB-269970 hydrochloride (SB-269970A) , a hydrochloride salt form of SB-269970, is a 5-HT7 receptor antagonist (pKi of 8.3) and exhibits >50-fold selectivity against other receptors. |
靶点活性 | 5-HT7:8.3(pKi) |
体外活性 | SB-269970 inhibits 5-CT-stimulated adenylyl cyclase activity in guinea-pig hippocampal membranes. SB-269970 (0.03 μM, 0.1 μM, 0.3 μM and 1 μM) produces a concentration-related rightward-shift of the 5-CT concentration-response curve with no significant alteration in the maximal response to 5-CT. [1] SB-269970 (1 μM) has any effect on 5-HT efflux when superfused alone. [2] |
体内活性 | SB-269970 (10 mg/kg and 30 mg/kg) significantly reduces the effects of amphetamine by 25 and 27%, respectively, and blocks the effects of ketamine by 38% (10 mg/kg) and 30% (30 mg/kg). SB-269970 significantly reduces amphetamine-induced hyperactivity in wild-type mice and is without effects in 5-HT7 knockout mice. Systemic administration of SB-269970 (30 mg/kg) significantly reverses amphetamine disruption of PPI and did not enhance PPI by itself compared to control. [3] SB-269970 significantly reverses the deficits induced by MK-801, but not by scopolamine. SB-269970 normalizes MK-801-induced glutamate but not dopamine release in the cortex. [4] SB-269970 (in one medium dose of 0.5 or 1 mg/kg) exerts a specific antianxiety-like effect in the Vogel drinking test in rats, in the elevated plus-maze test in rats and in the four-plate test in mice. Moreover, SB-269970 (in one medium dose of 5 or 10 mg/kg) reveals antidepressant-like activity in the forced swimming and the tail suspension tests in mice. [5] SB-269970 at doses of 0.3, 1 and 3 μg exhibits an anticonflict effect which is weaker than that of diazepam (40 μg), whereas SB-269970 at doses of 3 and 10 μg had marked anti-immobility action comparable to that of imipramine (0.1 μg). [6] |
别名 | SB-269970A, SB269970 HCl |
分子量 | 388.95 |
分子式 | C18H28N2O3S·HCl |
CAS No. | 261901-57-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 7.8 mg/mL (20 mM)
DMSO: 38.9 mg/mL (100 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O / DMSO | 1 mM | 2.571 mL | 12.8551 mL | 25.7102 mL | 64.2756 mL |
5 mM | 0.5142 mL | 2.571 mL | 5.142 mL | 12.8551 mL | |
10 mM | 0.2571 mL | 1.2855 mL | 2.571 mL | 6.4276 mL | |
20 mM | 0.1286 mL | 0.6428 mL | 1.2855 mL | 3.2138 mL | |
DMSO | 50 mM | 0.0514 mL | 0.2571 mL | 0.5142 mL | 1.2855 mL |
100 mM | 0.0257 mL | 0.1286 mL | 0.2571 mL | 0.6428 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
SB-269970 hydrochloride 261901-57-9 GPCR/G Protein Neuroscience 5-HT Receptor SB 269970 5-hydroxytryptamine Receptor SB 269970 Hydrochloride SB269970 hydrochloride SB 269970 hydrochloride SB269970 SB-269970A Inhibitor SB-269970 Hydrochloride SB269970 HCl SB269970 Hydrochloride SB-269970 inhibit Serotonin Receptor inhibitor